Ajan Reginald
Patrimonio netto: 2 M $ in data 31/12/2025
Patrimonio netto: 2 M $ in data 31/12/2025
Ajan Trevor Reginald is the founder of Cell Therapy Ltd., established in 2009, serving as Chief Executive Officer & Executive Director.
Current jobs include Chairman at Oncogeni Ltd., Director at Desktop Genetics Ltd., and Managing Director, Secretary & Executive Director at Cardiogeni Plc since 2019.
Former jobs include Director-Business Development at Roche Pharmaceuticals, Inc., Chief Executive Director & Executive Director at Coiled Therapeutics Plc from 2022 to 2025, Global Head-Emerging Technologies at Roche Group, and Chief Operating & Technology Officer at Novacyt SAS. Education history includes graduate studies at the University of Oxford, undergraduate studies at the University of London, and an MBA from Kellogg School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 24,94% | 21/04/2026 | 22.223.711 ( 24,94% ) | 2 M $ | 31/12/2025 |
| 24/11/2025 | 380.508 ( 0,09% ) | 49 926 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Fondatore | 01/01/2009 |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Amministratore Delegato | 28/12/2016 |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Direttore/Membro del Consiglio | - |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
| ROQT THER | Amministratore Delegato | 17/03/2025 |
| NOVACYT | Direttore operativo | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale